DOAJ Open Access 2020

627 The DLL3-targeted half-life extended bispecific T cell engager (HLE BiTE®) immune-oncology therapy AMG 757 has potent antitumor activity in neuroendocrine cancer

Keegan Cooke Jinghui Zhan Juan Estrada Marie-Anne Damiette Smit Aditya Shetty +2 lainnya

Penulis (7)

K

Keegan Cooke

J

Jinghui Zhan

J

Juan Estrada

M

Marie-Anne Damiette Smit

A

Aditya Shetty

J

Jonathan Werner

F

Fei Lee

Format Sitasi

Cooke, K., Zhan, J., Estrada, J., Smit, M.D., Shetty, A., Werner, J. et al. (2020). 627 The DLL3-targeted half-life extended bispecific T cell engager (HLE BiTE®) immune-oncology therapy AMG 757 has potent antitumor activity in neuroendocrine cancer. https://doi.org/10.1136/jitc-2020-SITC2020.0627

Akses Cepat

PDF tidak tersedia langsung

doi.org/10.1136/jitc-2020-SITC2020.0627
Informasi Jurnal
Tahun Terbit
2020
Sumber Database
DOAJ
DOI
10.1136/jitc-2020-SITC2020.0627
Akses
Open Access ✓